SonoMotion receives FDA Breakthrough Device Designation for Break Wave™ procedure.


Sonomotion raises USD$12.4 Million in Series C funding to advance development of Break Wave™. Round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.


Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).


First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video).


Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL. Article selected for the cover of the May edition (press release).